These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29129543)

  • 1. Idiopathic elastosis perforans serpiginosa with satisfactory response after 5-ALA photodynamic therapy.
    Alique-García S; Company-Quiroga J; Horcajada-Reales C; Echeverría-García B; Tardío-Dovao JC; Borbujo J
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():55-57. PubMed ID: 29129543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of d-penicillamine induced elastosis perforans serpiginosa with ALA-PDT.
    Wang D; Liang J; Xu J; Chen L
    Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):140-2. PubMed ID: 25463318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid.
    Takeda H; Kaneko T; Harada K; Matsuzaki Y; Nakano H; Hanada K
    Dermatology; 2005; 211(3):264-6. PubMed ID: 16205072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy.
    Rkein AM; Ozog DM
    Dermatol Clin; 2014 Jul; 32(3):415-25, x. PubMed ID: 24891062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy: a review of the literature and image documentation.
    Issa MC; Manela-Azulay M
    An Bras Dermatol; 2010; 85(4):501-11. PubMed ID: 20944910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
    Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
    J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-oncologic indications for ALA-PDT.
    Szeimies RM; Landthaler M; Karrer S
    J Dermatolog Treat; 2002; 13 Suppl 1():S13-8. PubMed ID: 12060512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of photodynamic therapy in dermatology: results of a consensus conference.
    Nestor MS; Gold MH; Kauvar AN; Taub AF; Geronemus RG; Ritvo EC; Goldman MP; Gilbert DJ; Richey DF; Alster TS; Anderson RR; Bank DE; Carruthers A; Carruthers J; Goldberg DJ; Hanke CW; Lowe NJ; Pariser DM; Rigel DS; Robins P; Spencer JM; Zelickson BD
    J Drugs Dermatol; 2006 Feb; 5(2):140-54. PubMed ID: 16485882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes in topical photodynamic therapy.
    Dragicevic-Curic N; Fahr A
    Expert Opin Drug Deliv; 2012 Aug; 9(8):1015-32. PubMed ID: 22731896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The advantages of aminolevulinic acid photodynamic therapy in dermatology.
    Taylor EL; Brown SB
    J Dermatolog Treat; 2002; 13 Suppl 1():S3-11. PubMed ID: 12060511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer.
    Ibbotson SH
    Br J Dermatol; 2002 Feb; 146(2):178-88. PubMed ID: 11903225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical photodynamic therapy in clinical dermatology.
    Kormeili T; Yamauchi PS; Lowe NJ
    Br J Dermatol; 2004 Jun; 150(6):1061-9. PubMed ID: 15214890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical photodynamic therapy in dermatology.
    Szeimies RM; Calzavara-Pinton P; Karrer S; Ortel B; Landthaler M
    J Photochem Photobiol B; 1996 Nov; 36(2):213-9. PubMed ID: 9002264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The successful use of ALA-PDT in the treatment of recalcitrant molluscum contagiosum.
    Gold MH; Boring MM; Bridges TM; Bradshaw VL
    J Drugs Dermatol; 2004; 3(2):187-90. PubMed ID: 15098976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
    Morton CA
    J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting cellulitis of the scalp successfully treated with ALA-PDT: Case report.
    Zhan Y; Chen X; Zhou Y; Zou P; Xiao R
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():182-184. PubMed ID: 30290230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
    Boiy A; Roelandts R; de Witte PA
    J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.